The Physicians Committee for Responsible Medicine, a nonprofit that advances human-based science, and InSphero, a global leader in 3D in vitro technology for drug safety and efficacy testing, are ...

A human model of immune-driven liver injury Some drugs that pass early safety testing can still cause idiosyncratic drug-induced liver injury (iDILI)—a rare immune reaction that can lead to severe ...

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...

Liam Taylor, CEO, Axol Bioscience "We have built a unique set of products and services over the last decade to meet the growing requirements from the drug discovery and cosmetic industries to move ...

Scientists have achieved a groundbreaking advancement in preclinical testing by growing mini human livers, known as organoids, that can predict toxic drug reactions. This significant development, ...

The nonprofit said its new tool, using data from urine tests, has already picked up a spike of carfentanil, a potent and ...

A study by the MHRA will use AI and NHS data to predict side effects from drug combinations before they reach patients.

SAN FRANCISCO--(BUSINESS WIRE)--Tahoe Therapeutics today announced $30 million in new funding to build the definitive foundational dataset for training Virtual Cell Models. With this, the team will ...

Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...